Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP19A1 | P11511 | 5/20 | 0.42 |
| ▸ | TSHR | P16473 | 4/20 | 0.34 |
| ▸ | KIF11 | P52732 | 4/20 | 0.34 |
| ▸ | IDO1 | P14902 | 3/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.31 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.31 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.31 |
| ▸ | EGLN2 | Q96KS0 | 1/20 | 0.30 |
| ▸ | USP2 | O75604 | 1/20 | 0.30 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.30 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.30 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.30 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.30 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5447490 | 0.81 | ACHE (0.35) | TSHRKIF11ALDH1A1MAPK1CYP1A2 | |
| SCHEMBL3265568 | 0.81 | TSHR (0.39) | CYP19A1TSHRKIF11ALDH1A1MAPK1 | |
| SCHEMBL196785 | 0.81 | TSHR (0.50) | CYP19A1TSHRKIF11ALDH1A1MAPK1 | |
| SCHEMBL607283 | 0.80 | TSHR (0.58) | CYP19A1TSHRALDH1A1MAPK1NPSR1 | |
| SCHEMBL2865073 | 0.78 | CLK4 (0.38) | TSHRKIF11ALDH1A1MAPK1EGLN2 | |
| SCHEMBL2454679 | 0.78 | GRM5 (0.40) | TSHRKIF11IDO1EGLN2CYP1A2 | |
| SCHEMBL3208807 | 0.75 | PTPN1 (0.37) | CYP19A1TSHRALDH1A1CYP1A2CYP3A4 | |
| SCHEMBL251722 | 0.74 | HSP90AA1 (0.38) | — | |
| SCHEMBL11778847 | 0.74 | CYP19A1 (0.49) | CYP19A1TSHRKIF11ALDH1A1MAPK1 | |
| SCHEMBL27830398 | 0.72 | HSP90AA1 (0.36) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20130299736-A1 | RADIATION-CURABLE COATING MATERIALS | BASE SE (DE) | 2013-11-14 | — | — | US | disclosed |
| US-20110230617-A1 | RADIATION-CURABLE COATING MATERIALS | BASF SE (DE) | 2011-09-22 | — | — | US | disclosed |
| US-20100126386-A1 | RADIATION-CURABLE COATING SUBSTANCES | BASF AKTIENGESELLSCHAFT (DE) | 2010-05-27 | — | — | US | disclosed |
| US-20060032390-A1 | Lithographic printing plate precursor and lithographic printing method | FUJI PHOTO FILM CO., LTD. | 2006-02-16 | — | — | US | disclosed |
| EP-0704765-B1 | A photoresist composition comprising a polyfunctional vinyl ether compound | SUMITOMO CHEMICAL CO (JP) | 1999-04-21 | — | — | EP | disclosed |
| US-5719008-A | PHOTOLITHOGRAPHY, COLOR FILTERS | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1998-02-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110230617-A1 | RADIATION-CURABLE COATING MATERIALS | RAD51, MGMT, RAD54L | CYP19A1 2434/4885TSHR 3653/4885KIF11 1701/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.